| Pharmaceutical Information |
| Drug Name |
Bacillus calmette-guerin |
| Drug ID |
BADD_D00207 |
| Description |
BCG vaccine has been investigated for the treatment of Neoplasms, Bladder Cancer, Neoplasms by Site, Urologic Diseases, and Urologic Neoplasms, among others. |
| Indications and Usage |
Not Available |
| Marketing Status |
Not Available |
| ATC Code |
L03AX03 |
| DrugBank ID |
DB12768
|
| KEGG ID |
D03063
|
| MeSH ID |
D001500
|
| PubChem ID |
6451
|
| TTD Drug ID |
D0A8LZ
|
| NDC Product Code |
0052-0602 |
| Synonyms |
BCG Vaccine | Vaccine, BCG | Bacillus Calmette Guerin Vaccine | Calmette's Vaccine | Calmette Vaccine | Calmettes Vaccine | Vaccine, Calmette's | Calmette Guerin Bacillus Vaccine |
|
| Chemical Information |
| Molecular Formula |
C21H14Br4O5S |
| CAS Registry Number |
76-60-8 |
| SMILES |
CC1=C(C(=C(C=C1C2(C3=CC=CC=C3S(=O)(=O)O2)C4=CC(=C(C(=C4C)Br)O)Br)Br)O)Br |
| Chemical Structure |
|
|
| ADR Related Proteins Induced by Drug |
| ADR Term |
Protein Name |
UniProt AC |
TTD Target ID |
PMID |
| Not Available | Not Available | Not Available | Not Available | Not Available |
|
| ADRs Induced by Drug |
|
|
